Tagrisso

Tagrisso is a medication used primarily for the treatment of certain types of non-small cell lung cancer (NSCLC). It is specifically designed for patients whose cancer has a specific genetic mutation known as EGFR T790M. Tagrisso works by targeting and inhibiting the activity of the mutated proteins that contribute to cancer cell growth and survival.

Benefits

• Tagrisso is effective in treating NSCLC with the EGFR T790M mutation, helping to slow the progression of the disease.
• It can improve survival rates and quality of life for patients with this specific type of lung cancer.

How to Use

Tagrisso is typically taken orally, once a day, with or without food. It is important to follow your healthcare provider’s instructions regarding dosage and administration to ensure the best possible outcome.

Possible Side Effects

• Common side effects may include diarrhea, rash, dry skin, and nail changes.
• More serious side effects can occur, such as lung problems, heart issues, and eye disorders. Contact your healthcare provider if you experience any severe or persistent symptoms.

Warnings and Precautions

• Before starting Tagrisso, inform your doctor about any other medical conditions or allergies you have.
• Tagrisso may interact with other medications, so it is important to discuss all current medications with your healthcare provider.
• Pregnant or breastfeeding women should not use Tagrisso, as it may harm the baby.

Storage

Store Tagrisso at room temperature, away from moisture and heat. Keep it out of reach of children and pets.

Additional Information

Tagrisso is available at YouDrugStore. Always consult with your healthcare provider for personalized medical advice and to ensure this medication is right for you.